Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)
JPY 57.0
(0.0%)
JPY 57.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.39 Billion JPY | 32.85% |
| 2022 | -1.94 Billion JPY | 23.38% |
| 2021 | -2.53 Billion JPY | -6.88% |
| 2020 | -2.37 Billion JPY | 21.71% |
| 2019 | -3.03 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -326.05 Million JPY | 25.36% |
| 2024 Q2 | -320.67 Million JPY | 5.82% |
| 2023 Q3 | -257.92 Million JPY | 6.28% |
| 2023 FY | - JPY | 32.85% |
| 2023 Q2 | -275.2 Million JPY | 34.95% |
| 2023 Q1 | -423.09 Million JPY | -33.96% |
| 2023 Q4 | -339.48 Million JPY | -31.62% |
| 2022 Q3 | -539.93 Million JPY | 0.0% |
| 2022 FY | - JPY | 23.38% |
| 2022 Q4 | -315.84 Million JPY | 41.5% |
| 2021 FY | - JPY | -6.88% |
| 2020 FY | - JPY | 21.71% |
| 2019 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | 245.399% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | -185.388% |
| GNI Group Ltd. | 14.48 Billion JPY | 109.615% |
| Linical Co., Ltd. | 1.24 Billion JPY | 211.693% |
| Trans Genic Inc. | 240.95 Million JPY | 678.152% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | -2.745% |
| Soiken Holdings Inc. | -583.2 Million JPY | -138.864% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | -130.988% |
| AnGes, Inc. | -8.86 Billion JPY | 84.277% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -8.368% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | 81.172% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | 1187.425% |
| NanoCarrier Co., Ltd. | -863 Million JPY | -61.422% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | -27.596% |
| CanBas Co., Ltd. | 53.65 Million JPY | 2696.537% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | -79.614% |
| RaQualia Pharma Inc. | -111.8 Million JPY | -1146.025% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | -14.965% |
| Kidswell Bio Corporation | -1.38 Billion JPY | -0.887% |
| PeptiDream Inc. | 7.37 Billion JPY | 118.886% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 27.809% |
| Ribomic Inc. | -1.01 Billion JPY | -37.583% |
| SanBio Company Limited | -4.52 Billion JPY | 69.214% |
| Healios K.K. | -3 Billion JPY | 53.672% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -19.496% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 0.637% |
| StemRIM | -2.03 Billion JPY | 31.444% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 206.631% |
| FunPep Company Limited | -952 Million JPY | -46.331% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -56.743% |
| Stella Pharma Corporation | -723.85 Million JPY | -92.452% |
| TMS Co., Ltd. | -937 Million JPY | -48.673% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -79.66% |
| Cuorips Inc. | -518 Million JPY | -168.932% |
| K Pharma,Inc. | 366.05 Million JPY | 480.559% |
| Takara Bio Inc. | 8.02 Billion JPY | 117.361% |
| ReproCELL Incorporated | 8.24 Million JPY | 16995.913% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | 1684.148% |
| StemCell Institute Inc. | 534.35 Million JPY | 360.701% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | 669.031% |
| CellSeed Inc. | -836.51 Million JPY | -66.532% |